0000899243-21-042213.txt : 20211101
0000899243-21-042213.hdr.sgml : 20211101
20211101192059
ACCESSION NUMBER: 0000899243-21-042213
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211031
FILED AS OF DATE: 20211101
DATE AS OF CHANGE: 20211101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Larson Yi
CENTRAL INDEX KEY: 0001785987
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40947
FILM NUMBER: 211368750
MAIL ADDRESS:
STREET 1: C/O TURNING POINT THERAPEUTICS, INC.
STREET 2: 10628 SCIENCE CENTER DRIVE, STE. 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LianBio
CENTRAL INDEX KEY: 0001831283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
BUSINESS ADDRESS:
STREET 1: C/O OGIER GLOBAL (CAYMAN) LIMITED
STREET 2: 89 NEXUS WAY, CAMANA BAY
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-9009
BUSINESS PHONE: 1 345 949 9876
MAIL ADDRESS:
STREET 1: C/O OGIER GLOBAL (CAYMAN) LIMITED
STREET 2: 89 NEXUS WAY, CAMANA BAY
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-9009
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-31
0
0001831283
LianBio
LIAN
0001785987
Larson Yi
C/O LIANBIO
103 CARNEGIE CENTER DRIVE, SUITE 215
PRINCETON
NJ
08540
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
16.00
2021-10-31
4
A
0
229538
0.00
A
2031-10-31
Ordinary Shares
229538
1196845
D
25% of the shares underlying the option shall vest and become exercisable on October 31, 2022; the remainder shall vest and become exercisable in three equal annual installments such that the option shall be fully vested on October 31, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.
By: /s/ Angela Chen, Attorney-in-Fact
2021-11-01